Skip to content

Evaluation of the effectiveness of the orexin receptor antagonist for type 2 diabetes with sleep disorder upon glycemic control.

Evaluation of the effectiveness of the orexin receptor antagonist for type 2 diabetes with sleep disorder upon glycemic control. - Evaluation of the effectiveness of the orexin receptor antagonist for type 2 diabetes with sleep disorder upon glycemic control.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026920
Enrollment
20
Registered
2017-04-17
Start date
2017-04-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Sponsors

Toda Chuo General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Adults who are 25 years or older and 80 years or younger 2.Type 2 diabetes patients 3.HbA1c 6.0% to 10.0% 4.Patients below BMI 35kg/m^2 5.Patients with Pittsburgh score 5.5 points or more 6.Patients who can understand consent sufficiently and having the agreement regarding participation in this examination

Exclusion criteria

Exclusion criteria: 1.Patients who are diagnosed type2 diabetes within 6 months 2.Patients who are not considered to take a general levels of diet therapy 3.Patients who take considerable levels of exercise 4.Excessive common custom drinker 5.Patients with severe liver disease 6.Patients who had severe hypoglycemia within 3 months 7.Patients who had a record of Anti-GAD Antibody positive 8.A pregnant woman or the woman who may be pregnant 9.Patients who are breastfeeding 10.Patients who take medications on a sleep disorder 11.Patients who will be considered inappropriate by an attendant physician

Design outcomes

Primary

MeasureTime frame
changes of validation by continuous glucose monitor (CGM)

Secondary

MeasureTime frame
changes of CES-D12, SF-8, parameters related to lipid, hepatic function and diabetes mellitus, 1 week later

Countries

Japan

Contacts

Public ContactTakuya Ishikawa

Toda Chuo General Hospital Internal Medicine

tactash@yahoo.co.jp0484421111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026